Vildagliptin - Wikipedia
WEBVildagliptin, sold under the brand name Galvus and others, is an oral anti-hyperglycemic agent (anti-diabetic drug) of the dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs.
Galvus (vildagliptin): What is it and is it FDA approved ... - Drugs.com
WEBNov 13, 2006 — Brand name: Galvus. Generic name: vildagliptin. Previous Name: LAF237. Company: Novartis Pharmaceuticals Corporation. Treatment for: Diabetes, Type 2. Galvus (vildagliptin) is a dipeptidyl peptidase 4 (DPP-4) inhibitor intended for use as a once-daily oral treatment for patients with type 2 diabetes.
Galvus: Uses, Side Effects, Benefits/Risks | Drugs.com
WEBWhat is Galvus? Galvus is a medicine that contains the active substance vildagliptin. It is available as tablets (50 mg). What is Galvus used for? Galvus is used to treat type-2 diabetes mellitus. It can be used in the following ways:
WEBGalvusMet is indicated in adults with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control: as initial therapy when diabetes is not adequately controlled by diet and exercise alone.
Vildagliptin: Uses, Interactions, Mechanism of Action - DrugBank …
WEBSummary. Vildagliptin is a once-daily dipeptidyl peptidase 4 (DPP-4) inhibitor used in the management of type 2 diabetes mellitus. Brand Names. Galvus, Jalra, Xiliarx. Generic Name. Vildagliptin. DrugBank Accession Number. DB04876. Background.
Vildagliptin. Vildagliptin for diabetes treatment - Patient
WEBOct 1, 2023 — Take vildagliptin exactly as your doctor tells you to. Swallow the tablets with a drink of water. The usual dose is one 50 mg tablet taken twice a day (Galvus® brand), although sometimes only one dose a day is needed depending on …
Galvus: Uses, Dosage, Side Effects, FAQ - MedicinesFAQ
WEBSep 19, 2023 — Galvus Uses, Dosage, Side Effects, Food Interaction and all others data. Galvus is a dipeptidyl peptidase-4 (DPP-4) inhibitor, which is believed to exert its actions in patients with type 2 diabetes by slowing the inactivation of incretin hormones.
Vildagliptin: a new option for managing type 2 diabetes
WEBVildagliptin (brand name Galvus), a dipeptyidyl-peptidase-4 (DPP-4) inhibitor (or ‘gliptin’), is an oral hypoglycaemic medication that is now fully funded for the treatment of type 2 diabetes. It is recommended for use after metformin as second- or third-line therapy for patients not achieving target HbA1c.
Positive results from Novartis five-year VERIFY study in type 2 ...
WEBSep 18, 2019 — About vildagliptin (Galvus®) Vildagliptin is approved as an oral treatment for adults with T2DM in more than 120 countries, including the EU, Japan, Latin America and Asia-Pacific.
Galvus - European Medicines Agency (EMA)
WEBGalvus is a diabetes medicine that is used together with diet and exercise to control the blood glucose (sugar) in adults with type 2 diabetes.